Cargando…
Germline BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance associated with breast/ovarian cancer: a report from North India
BACKGROUND: The spectrum of BRCA mutations that predispose to development of breast/ovarian cancer in Indian population remains unexplored. We report incidence and various types of pathogenic, likely pathogenic and variants of unknown significance (VUS) mutations in BRCA1 and BRCA2 genes observed at...
Autores principales: | Mehta, Anurag, Vasudevan, Smreti, Sharma, Sanjeev Kumar, Kumar, Dushyant, Panigrahi, Manoj, Suryavanshi, Moushumi, Gupta, Garima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280886/ https://www.ncbi.nlm.nih.gov/pubmed/30555256 http://dx.doi.org/10.2147/CMAR.S186563 |
Ejemplares similares
-
Predictive biomarkers in nonsmall cell carcinoma and their clinico-pathological association
por: Mehta, Anurag, et al.
Publicado: (2019) -
Diagnostic ability of real-time quantitative polymerase chain reaction versus immunohistochemistry for Ki-67 assessment in breast cancer: An Indian perspective
por: Mehta, Anurag, et al.
Publicado: (2019) -
ROS1 rearrangement and response to crizotinib in Stage IV non-small cell lung cancer
por: Suryavanshi, Moushumi, et al.
Publicado: (2017) -
Clinical significance of variants of unknown significances in BRCA genes
por: Choi, Min Chul
Publicado: (2019) -
Droplet digital polymerase chain reaction offers an improvisation over conventional immunohistochemistry and fluorescent in situ hybridization for ascertaining Her2 status of breast cancer
por: Suryavanshi, Moushumi, et al.
Publicado: (2019)